Indaptus Therapeutics INDP
NASDAQ INDP
$3.13 -0.08 (-2.49%)
As of: Nov 12, 2026 · 1:52 PM EST

Indaptus Therapeutics (INDP) Sales of Property, Plant and Equipment (2022)

Updated

Indaptus Therapeutics (INDP) recorded Sales of Property, Plant and Equipment of $172,555 in FY2022, down 61.8% from $451,600 in FY2021.

Analysis

Indaptus Therapeutics (INDP) Sales of Property, Plant and Equipment (2022) Analysis & Trends

  • Per Business Quant data, INDP's Sales of Property, Plant and Equipment was $451,600 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Indaptus Therapeutics 185.93 Mn 158.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 172,555.00
API Access

Indaptus Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=INDP&period=max&api_key=YOUR_API_KEY